-
But Rosen's foundation can pay his lab for its work with companies such as Exelixis and TargeGen that are testing anti-JAK2 drugs.
FORBES: Magazine Article
-
That meant that JAK2-blocking drugs might work for patients like Pritzker, too.
FORBES: Patient Power
-
The first time the group of researchers met, he piped up with research showing that mutations in genes related to JAK2 could also cause the disease.
FORBES: Patient Power
-
Now there are seven anti-JAK2 drugs in clinical trials.
FORBES: Magazine Article